EndoQuest Robotics announced today that the FDA approved the initiation of the next and final stage of its PARADIGM trial.
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback